+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunoprotein Diagnostic Testing Market - Global Forecast 2025-2030- Product Image
Immunoprotein Diagnostic Testing Market - Global Forecast 2025-2030- Product Image
Sale

Immunoprotein Diagnostic Testing Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888817
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immunoprotein diagnostic testing market is witnessing sustained expansion as healthcare systems invest in advanced technologies that enhance clinical decision-making and patient care. This report provides senior leaders with a strategic overview and actionable intelligence to navigate the shifting landscape, enabling informed investments and operational resilience.

Market Snapshot: Immunoprotein Diagnostic Testing at a Glance

The Immunoprotein Diagnostic Testing Market grew from USD 9.41 billion in 2024 to USD 10.07 billion in 2025. It is expected to continue growing at a CAGR of 6.94%, reaching USD 14.08 billion by 2030. Driven by technological progress and rising focus on precision medicine, this sector is rapidly evolving across major global regions. The market’s foundation supports both centralized laboratory diagnostics and point-of-care solutions, integrating new assay technologies and digital platforms to address a range of clinical challenges.

Scope & Segmentation: Defining Key Influencers Across the Value Chain

  • Assay Types: Antibody tests (IgA, IgE, IgG, IgM, total antibody), antigen tests, and autoantibody tests.
  • Technologies: CLIA, ELISA, fluorescence polarization immunoassay, lateral flow immunoassay, and Western blot systems.
  • End Users: Clinics, diagnostic laboratories, hospitals, and research institutes.
  • Applications: Autoimmune disorders (multiple sclerosis, rheumatoid arthritis, Sjögren syndrome, type 1 diabetes), cardiovascular diseases, infectious diseases (COVID-19, hepatitis, HIV, influenza), and oncology.
  • Sample Types: Plasma, serum, urine, whole blood.
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, South Africa, and others); Asia-Pacific (China, India, Japan, Australia, South Korea, and additional markets).
  • Leading Companies: F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Thermo Fisher Scientific Inc, Danaher Corporation, Ortho-Clinical Diagnostics, Inc., bioMérieux SA, DiaSorin S.p.A, Bio-Rad Laboratories, Inc., Fujirebio Inc.

Key Takeaways: Strategic Insights for Decision-Makers

  • Immunoprotein diagnostic testing is moving beyond traditional laboratory settings to support immediate clinical interventions, reflecting the integration of point-of-care and digital technologies.
  • Assay innovation and automation have improved both speed and accuracy, supporting streamlined workflows and deeper immunological profiling.
  • Collaborations between diagnostics manufacturers, technology developers, and academic institutions have accelerated standardization and enhanced regulatory compliance.
  • With the proliferation of high-sensitivity platforms, laboratories are equipped to handle both routine and specialized testing, improving disease monitoring and patient stratification.
  • Regional healthcare strategies drive divergent adoption trends, as investment levels and regulatory frameworks vary considerably across the Americas, EMEA, and Asia-Pacific.

Tariff Impact: Navigating Supply Chain and Pricing Pressures

Recent United States tariffs have prompted diagnostic manufacturers and distributors to reevaluate their procurement and supply chain models. Cost pressures from increased duties have led to shifts such as local sourcing, supplier diversification, and domestic capacity expansion. Industry and government collaboration is seeking targeted exemptions to preserve access to essential diagnostic components, ensuring operational resilience in a rapidly changing policy climate.

Methodology & Data Sources

This report leverages primary interviews with laboratory directors, R&D leaders, and industry procurement managers, supported by a comprehensive review of secondary sources such as peer-reviewed journals and regulatory databases. Analytical frameworks apply both thematic and quantitative validation to ensure findings reflect current industry realities.

Why This Report Matters

  • Gain a strategic view of the immunoprotein diagnostic testing evolution, spotlighting new technology adoption and emerging clinical applications.
  • Identify market opportunities and risks by understanding impacts of regulatory shifts and supply chain adjustments.
  • Support high-confidence investment and procurement strategies grounded in unbiased, expert-driven market analysis.

Conclusion

This analysis equips senior decision-makers with the clarity to respond to evolving market forces in immunoprotein diagnostics. The integration of automation, digital analytics, and collaborative innovation will shape industry growth and future clinical outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of multiplex immunoassays for simultaneous detection of multiple protein biomarkers in clinical diagnostics
5.2. Adoption of point-of-care immunoprotein testing platforms for rapid infectious disease screening in emergency settings
5.3. Development of ultrasensitive immunoassays leveraging nanotechnology for early detection of low-abundance immunoproteins
5.4. Implementation of automated immunoprotein analyzers with artificial intelligence-driven quality control and data interpretation
5.5. Emergence of microfluidics-based immunoprotein tests for high-throughput prenatal and neonatal screening applications
5.6. Growth of immunoprotein biomarkers utilization in personalized oncology treatment monitoring and prognosis prediction
5.7. Expansion of lab-developed immunoprotein assays for autoimmune disorder diagnosis with enhanced specificity and sensitivity
5.8. Regulatory shifts influencing immunoprotein test validation protocols and reimbursement frameworks in key markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immunoprotein Diagnostic Testing Market, by Assay Type
8.1. Introduction
8.2. Antibody Test
8.2.1. Iga
8.2.2. Ige
8.2.3. Igg
8.2.4. Igm
8.2.5. Total Antibody
8.3. Antigen Test
8.4. Autoantibody Test
9. Immunoprotein Diagnostic Testing Market, by Technology
9.1. Introduction
9.2. Clia
9.3. Elisa
9.4. Fluorescence Polarization Immunoassay
9.5. Lateral Flow Immunoassay
9.6. Western Blot
10. Immunoprotein Diagnostic Testing Market, by End User
10.1. Introduction
10.2. Clinic
10.3. Diagnostic Laboratory
10.4. Hospital
10.5. Research Institute
11. Immunoprotein Diagnostic Testing Market, by Application
11.1. Introduction
11.2. Autoimmune Disorders
11.2.1. Multiple Sclerosis
11.2.2. Rheumatoid Arthritis
11.2.3. Sjogren Syndrome
11.2.4. Type 1 Diabetes
11.3. Cardiovascular Diseases
11.4. Infectious Diseases
11.4.1. COVID-19
11.4.2. Hepatitis
11.4.3. Hiv
11.4.4. Influenza
11.5. Oncology
12. Immunoprotein Diagnostic Testing Market, by Sample Type
12.1. Introduction
12.2. Plasma
12.3. Serum
12.4. Urine
12.5. Whole Blood
13. Americas Immunoprotein Diagnostic Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Immunoprotein Diagnostic Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Immunoprotein Diagnostic Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Siemens Healthineers AG
16.3.4. Thermo Fisher Scientific Inc
16.3.5. Danaher Corporation
16.3.6. Ortho-Clinical Diagnostics, Inc.
16.3.7. bioMérieux SA
16.3.8. DiaSorin S.p.A
16.3.9. Bio-Rad Laboratories, Inc.
16.3.10. Fujirebio Inc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: RESEARCHAI
FIGURE 26. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: RESEARCHSTATISTICS
FIGURE 27. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: RESEARCHCONTACTS
FIGURE 28. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGG, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGG, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGM, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGM, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TOTAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TOTAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIGEN TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIGEN TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOANTIBODY TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOANTIBODY TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CLIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CLIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY FLUORESCENCE POLARIZATION IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY FLUORESCENCE POLARIZATION IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY WESTERN BLOT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SJOGREN SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SJOGREN SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COVID-19, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COVID-19, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HEPATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HIV, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HIV, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFLUENZA, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 130. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 131. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 138. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 139. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 140. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 141. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 146. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 147. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 156. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 157. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 225. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 226. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 227. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 228. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 229. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 236. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 237. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 238. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 239. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 240. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 241. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 242. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 243. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 244. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 245. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 252. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 253. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 254. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 255. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 256. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 273. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 274. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 275. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 276. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 277. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 284. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2025-2030 (USD MILLION)
TABLE 285. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 286. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 287. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 288. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 289. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 290. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 291. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 292. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 293. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 294. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 295. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2024 (USD MILLION)
TABLE 300. SPAIN IMMUNOPROTEIN DIAGNOSTIC TES

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Immunoprotein Diagnostic Testing market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc
  • Danaher Corporation
  • Ortho-Clinical Diagnostics, Inc.
  • bioMérieux SA
  • DiaSorin S.p.A
  • Bio-Rad Laboratories, Inc.
  • Fujirebio Inc

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.07 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.08 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Immunoprotein Diagnostic Testing - Global Strategic Business Report - Product Image

Immunoprotein Diagnostic Testing - Global Strategic Business Report

  • Report
  • 171 Pages
  • Global
From
Immunoprotein Market - Global Forecast 2025-2030 - Product Image

Immunoprotein Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Czechia IVD Market Shares and Forecasts for 500 Major Blood Banking, Cancer, Chemistry, Coagulation, Drugs of Abuse, Endocrine, Flow Cytometry, Hematology, Immunodiagnostic, Immunoprotein, Infectious Diseases, Molecular Diagnostic, TDM Tests - Product Image

Czechia IVD Market Shares and Forecasts for 500 Major Blood Banking, Cancer, Chemistry, Coagulation, Drugs of Abuse, Endocrine, Flow Cytometry, Hematology, Immunodiagnostic, Immunoprotein, Infectious Diseases, Molecular Diagnostic, TDM Tests

  • Report
  • Global
From

About the Immunoprotein Testing Market

Immunoprotein testing is a type of diagnostic test used to detect the presence of specific proteins in the body. These proteins are produced by the immune system in response to a variety of conditions, including infections, autoimmune diseases, and cancer. Immunoprotein tests are used to diagnose and monitor a wide range of diseases, including HIV, hepatitis, and tuberculosis. They can also be used to detect the presence of antibodies, which can indicate a previous exposure to a particular virus or bacteria. Immunoprotein tests are typically performed in a laboratory setting, using a variety of techniques such as enzyme-linked immunosorbent assays (ELISA) and immunofluorescence assays (IFA). These tests are often used in combination with other diagnostic tests, such as blood tests, to provide a more comprehensive picture of a patient's health. The immunoprotein testing market is a rapidly growing segment of the diagnostics industry. It is driven by the increasing prevalence of infectious diseases, the growing demand for personalized medicine, and the development of new technologies. Some of the major players in the immunoprotein testing market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, DiaSorin, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.